Tech Company Financing Transactions
OncoPrecision Funding Round
On 10/31/2022, OncoPrecision raised $3.3 million in Seed funding from Creative Ventures, Foundation for the Progress of Medicine and GRIDX.
Transaction Overview
Company Name
Announced On
10/31/2022
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Seed
Proceeds Purpose
The company will use the funds to Improve Cancer Patient Outcomes and Drug Development Efforts with "Patient Micro Avatars"
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Sevilla 2940
Buenos Aires, 1425
AR
Buenos Aires, 1425
AR
Phone
Undisclosed
Website
Email Address
Overview
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tarek Zaki
Co-Founder
Candelaria Ríos
Co-Founder
Gastón Soria
Browse more venture capital transactions:
Prev: 10/31/2022: Everyangle venture capital transaction
Next: 10/31/2022: Eagle Genomics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs